OP0002 Tofacitinib in Patients with Ankylosing Spondylitis: A Phase 2, 16-Week, Randomised, Placebo-Controlled, Dose-Ranging Study

20167 citationsJournal Article

Authors

Good health and well-being

Published in: Annals of the Rheumatic Diseases

Volume 75, pp. 52-53

Field-Weighted Citation Impact: 2.06